The Rechts der Isar Hospital is a hospital in the Haidhausen district of Munich, Germany. It is the teaching hospital and biomedical research facility of the TUM School of Medicine.

There are 1,161 beds in Klinikum rechts der Isar.

During the past decade, Klinikum rechts der Isar conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum rechts der Isar" #1 sponsor was "Technical University of Munich" with 16 trials, followed by "Deutsches Herzzentrum Muenchen" with 5 trials sponsored, "University of Ulm" with 5 trials sponsored, "Mauna Kea Technologies" with 2 trials sponsored and "Abbott Diagnostics Division" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum rechts der Isar" #1 collaborator was "Technical University of Munich" with 4 trials as a collaborator, "Cellvizio Inc." with 2 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 2 trials as a collaborator, "Emissary International LLC" with 2 trials as a collaborator and "Ludwig-Maximilians - University of Munich" with 2 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar" are "Acute Myeloid Leukemia" (4 trials), "Coronary Heart Disease" (3 trials), "AJCC Stage II and III" (1 trials), "Adenocarcinoma" (1 trials) and "Anesthesia" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar" in a lesser frequency.

Most popular intervention types in "Klinikum rechts der Isar" are "Device" (17 trials), "Drug" (13 trials), "Procedure" (12 trials), "Other" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (3 trials), "Idarubicin" (3 trials), "All-trans retinoic acid" (2 trials), "Etoposide" (2 trials) and "Mitoxantrone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum rechts der Isar" are 49 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum rechts der Isar". 1 are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Klinikum rechts der Isar, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum rechts der Isar, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".